Ouedraogo L, Magnon M, Sawadogo L, Tricoche R
Département de Biologie et Physiologie Animales, Faculté des Sciences et Techniques (FAST) Université de Ouagadougou, Burkina Faso.
Fundam Clin Pharmacol. 1998;12(2):133-42. doi: 10.1111/j.1472-8206.1998.tb00933.x.
Earlier experiments only revealed involvement of sympathetic pre-synaptic dopaminergic receptors in dopamine induced inotropism in myocardium. We therefore used electrically stimulated (1 Hz) isolated 7-day-old chick embryo heart ventricles, thought to be devoid of functional sympathetic nerves, to re-investigate post-synaptic receptors involvement and particularly that of dopaminergic receptors in the positive inotropic effect of dopamine. The results showed that noradrenaline, isoprenaline and dopamine produced a positive inotropic effect with a similar efficacy and with an order of potency as follows: Isoprenaline = Noradrenaline > Dopamine. Tyramine induced no significant modification of the "initial tension" indicating that functional sympathetic innervation and/or releasable endogenous catecholamines were not demonstrable in the 7-day-old chick embryo heart ventricle. Propranolol (1 microM) competitively antagonized the positive inotropic response to isoprenaline, noradrenaline and dopamine, meanwhile phentolamine (3 microM) failed to significantly modify the effects of both noradrenaline and dopamine, indicating that these catecholamines induced their positive inotropic effects via stimulation of beta-adrenoceptors; involvement of alpha-adrenergic receptors stimulation was not demonstrable in these effects. Moreover, haloperidol (2 microM) antagonized the positive inotropic response to dopamine but had not any significant effect on the response to isoprenaline. The combined application of both propranolol and haloperidol antagonized the positive inotropic response to dopamine to a greater extent than when these two antagonists were given alone. Consequently, post-synaptic dopaminergic receptors were also involved in the positive inotropic effect of dopamine. Furthermore, in preparations in which sodium channels were inactivated by high potassium physiological salt solution, high concentrations of dopamine (0.1 mM to 1 mM) induced a slow developing electrical and positive inotropic responses which were also inhibited by propranolol and haloperidol, but not by phentolamine. These latter results indicated that like beta-adrenergic stimulation, the slow inward calcium current activated by stimulation of adenylate cyclase, was at least in part involved in the positive inotropic response to dopamine. In conclusion, dopamine induced its positive inotropism via stimulation of post-synaptic beta-adrenergic and dopaminergic receptors. The contribution of dopaminergic receptors in this positive inotropic effect might be of the DA-2 receptors since haloperidol used had been reported to be more DA-2 than DA-1 antagonist. These DA-2 receptors subtypes would mediate activation of adenylate cyclase.
早期实验仅揭示了交感神经节前多巴胺能受体参与多巴胺诱导的心肌变力作用。因此,我们使用电刺激(1赫兹)的7日龄鸡胚心脏心室(认为其缺乏功能性交感神经),重新研究突触后受体的参与情况,特别是多巴胺能受体在多巴胺正性变力作用中的参与情况。结果显示,去甲肾上腺素、异丙肾上腺素和多巴胺产生了相似效力的正性变力作用,其效能顺序如下:异丙肾上腺素 = 去甲肾上腺素 > 多巴胺。酪胺未引起“初始张力”的显著改变,表明在7日龄鸡胚心脏心室中未检测到功能性交感神经支配和/或可释放的内源性儿茶酚胺。普萘洛尔(1微摩尔)竞争性拮抗对异丙肾上腺素、去甲肾上腺素和多巴胺的正性变力反应,而酚妥拉明(3微摩尔)未能显著改变去甲肾上腺素和多巴胺的作用,表明这些儿茶酚胺通过刺激β - 肾上腺素能受体诱导其正性变力作用;在这些作用中未检测到α - 肾上腺素能受体刺激的参与。此外,氟哌啶醇(2微摩尔)拮抗对多巴胺的正性变力反应,但对异丙肾上腺素的反应无显著影响。普萘洛尔和氟哌啶醇联合应用比单独给予这两种拮抗剂时更大程度地拮抗对多巴胺的正性变力反应。因此,突触后多巴胺能受体也参与了多巴胺的正性变力作用。此外,在高钾生理盐溶液使钠通道失活的制剂中,高浓度的多巴胺(0.1毫摩尔至1毫摩尔)诱导缓慢发展的电反应和正性变力反应,这些反应也被普萘洛尔和氟哌啶醇抑制,但未被酚妥拉明抑制。后一结果表明,与β - 肾上腺素能刺激一样,由腺苷酸环化酶刺激激活的缓慢内向钙电流至少部分参与了对多巴胺的正性变力反应。总之,多巴胺通过刺激突触后β - 肾上腺素能和多巴胺能受体诱导其正性变力作用。多巴胺能受体在这种正性变力作用中的贡献可能是DA - 2受体,因为据报道所用的氟哌啶醇是比DA - 1拮抗剂更强的DA - 2拮抗剂。这些DA - 2受体亚型将介导腺苷酸环化酶的激活。